BriaCell Therapeutics Corp. | Balance Sheet
Fiscal year is August-July. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,515.70
2,623.70
1,572.10
1,071.90
2,014.40
2,279.50
Total Accounts Receivable
10.70
7.80
35.30
3.50
7.00
19
Other Current Assets
0.90
0.60
13.40
13.20
15.40
147.70
Total Current Assets
1,527.30
2,632.20
1,620.80
1,088.50
2,036.80
2,446.20
Net Property, Plant & Equipment
5,126.20
-
1.70
0.60
-
-
Total Investments and Advances
29.00
30.50
37.80
0.00
0.00
-
Intangible Assets
-
-
0.00
0.00
0.00
358
Other Assets
3,011.90
161.60
-
2.50
2.40
173
Total Assets
9,694.40
2,824.30
1,660.30
1,091.60
2,039.20
2,977.10
Accounts Payable
76.70
35.10
-
-
-
Other Current Liabilities
-
1,969.60
152.40
63.50
1,104.10
Total Current Liabilities
76.70
2,004.70
152.40
63.50
1,104.10
Total Liabilities
76.70
2,004.70
152.40
63.50
1,104.10
Common Equity (Total)
9,617.60
819.60
1,507.90
1,028.10
935.10
Total Shareholders' Equity
9,617.60
819.60
1,507.90
1,028.10
935.10
Total Equity
9,617.60
819.60
1,507.90
1,028.10
935.10
Liabilities & Shareholders' Equity
9,694.40
2,824.30
1,660.30
1,091.60
2,039.20
About BriaCell Therapeutics
View Profile
